Dr. Mark Perazella, Internationally Renowned Nephrologist, Retires at Year End
Mark Perazella’s colleagues single him out not only for his extraordinary accomplishments in the field of nephrology, but for his kindness, humility, and commitment to mentoring others. Perazella, MD, is professor of medicine (nephrology), director of the Acute Dialysis Unit at Yale New Haven Hospital, and medical director of both the on-campus Yale Physician Associate (PA) Program and the online Yale Physician Assistant Program. He will retire at the end of this year as professor of medicine emeritus.
Thalidomide Use In Gastrointestinal Bleeding
Angiodysplasia, a type of benign vascular lesion made up of dilated blood vessels, is a common source of gastrointestinal bleeding from the small intestine. A recent editorial from Yale Internal Medicine’s Loren Laine, MD, professor of medicine and chief of digestive diseases, in the New England Journal of Medicine highlights novel findings from a recent multicenter, double-blind, randomized clinical trial evaluating thalidomide in the treatment of angiodysplasia-related bleeding.
Dr. Kyle Bramley Leads Interventional Pulmonary Program
The Yale Interventional Pulmonary team in Yale’s Section of Pulmonary, Critical Care, and Sleep Medicine (Yale-PCCSM) employs advanced technologies to diagnose and treat diseases in the chest, such as lung nodules and masses, lymph node enlargement, complex airways, and pleural effusions. The program, led by Kyle Bramley, MD, assistant professor of medicine (pulmonary), was one of the first interventional pulmonology programs in Connecticut when it was established in 2009. Today it remains the largest interventional pulmonary service in the state.
Welcome New Staff, Faculty, Postdoctoral Associates/Fellows & Postgraduate Associates/Fellows (Nov. 2023)
The Department of Internal Medicine is pleased to welcome the following new faculty, staff members, postgraduate associates / fellows, and postgraduate associates / fellows who joined us in October 2023...
Alcohol Research Conference Fosters Collaboration Across Specialties
Now in its second year, the Yale Conference for Alcohol Research and Education (YCARE) was held on September 30, 2023. Offering a comprehensive agenda of talks, panel discussions, and poster presentations, the all-day event brought together Yale's researchers, clinicians, and other stakeholders under the banner of alcohol research. Bubu Banini, MD, PhD, assistant professor of medicine (digestive diseases), Yale School of Medicine (YSM), spearheaded the conference, along with co-directors David Fiellin, MD, professor of medicine (general medicine) and emergency medicine, YSM, and public health, Yale School of Public Health; Graeme Mason, PhD, professor of radiology and biomedical imaging and of psychiatry, YSM; and Sherry McKee, PhD, professor of psychiatry, YSM.
Discovering the 'Cytokine Language' That Activates Immune Responses
Using a new computational method based on a causal inference framework, CINEMA-OT, the Yale team studied how individual immune cells react to combinations of cytokines, or small proteins released by cells that regulate inflammation. They discovered that certain cytokines have a synergistic effect, inducing unique gene activation programs compared to their individual effects. This cryptography of cytokine signals acts as a language, instructing immune cells.
Dr. Jorge Moreno Honored with Emerging Trailblazer Award by Latino Alumni Association of Columbia University
On October 13, 2023, the Latino Alumni Association of Columbia University (LAACU) honored Jorge Moreno, MD, assistant professor of medicine (general internal medicine), with the Emerging Trailblazer Award at their annual gala during Latinx Heritage Month. The award recognizes “selfless individuals for their achievements and positive influence on the Latinx community.”
Offering Specialized Care & Research For Patients with Cancer and HIV
Patients living at this unique intersection of HIV and cancer face complex medical challenges, and traditional cancer care pathways often do not effectively address the specific needs of individuals with HIV. Brinda Emu, MD, PhD, associate professor of medicine (infectious diseases), and Jill Lacy, MD, professor of medicine (medical oncology), realized that a dedicated effort was required to offer comprehensive care, as well as investigate the scientific underpinnings of these conditions.
NIDA Invests Nearly $7M to Address the Opioid Crisis Among Women Who Experience Intimate Partner Violence
The National Institutes of Health and National Institute on Drug Abuse has awarded nearly $7 million to MPIs Tami Sullivan, PhD (Psychiatry and Public Health); E. Jennifer Edelman, MD, MHS (Internal Medicine and Public Health); and Dawn Johnson, PhD (University of Akron Department of Psychology) to study medication for opioid use disorder treatment retention among women who experience intimate partner violence.